v3.25.2
Contract Liabilities
6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Contract Liabilities

7. Contract liabilities

Contract liabilities represent the Group’s obligation to transfer services to a customer for which the Group has received advanced consideration, before the performance obligation has been satisfied. These liabilities are recognized when a customer prepays for services or when the Group has an unconditional right to consideration before the performance obligation is fulfilled.

Contract liabilities comprise entirely of advance consideration received from customers (deferred revenue) in respect of the AstraZeneca collaboration as of June 30, 2025. The current contract liabilities represent the amount of estimated revenue to be reported in the next 12 months related to amounts invoiced to its partners, while the non-current portion represents everything beyond 12 months. Current and non-current contract liabilities include future revenue from collaboration recharged expenses, upfront payments, and milestones achieved to June 30, 2025.

 

 

 

 

 

 

 

 

June 30, 2025

 

 

December 31, 2024

 

 

$000s

 

 

$000s

 

Contract liabilities:

 

 

 

 

 

 

Current

 

 

457

 

 

 

306

 

Non-current

 

 

56,310

 

 

 

51,790

 

Total contract liabilities at period end

 

 

56,767

 

 

 

52,096

 

 

 

 

 

 

 

 

Contract liabilities:

 

 

 

 

 

 

At January 1, 2024

 

 

81,572

 

 

 

 

Foreign exchange impact

 

 

(691

)

 

 

 

Additions during period

 

 

14,328

 

 

 

 

Revenue unwound during period

 

 

(43,113

)

 

 

 

At December 31, 2024

 

 

52,096

 

 

 

 

 

 

 

 

 

 

 

Contract liabilities:

 

 

 

 

 

 

At January 1, 2025

 

 

52,096

 

 

 

 

Foreign exchange impact

 

 

4,885

 

 

 

 

Additions during period

 

 

152

 

 

 

 

Revenue unwound during period

 

 

(366

)

 

 

 

At June 30, 2025

 

 

56,767